{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:15:30Z","timestamp":1790061330281,"version":"4.0.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:\u2002<\/jats:title>\n            <jats:p>Doxycycline is considered the first-line treatment of Lyme disease in adolescents and adults, but largely disproven concerns of permanent tooth staining prevented its use and evaluation in children &lt;8 years old. We sought to describe short-term adverse effects and treatment failures among young children receiving oral doxycycline for Lyme disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:\u2002<\/jats:title>\n            <jats:p>We completed a 2-pronged evaluation of children with Lyme disease treated with doxycycline. We performed a retrospective case series of patients &lt;8 years old who were diagnosed with Lyme disease and treated with doxycycline. We then performed a telephone follow-up survey study of the patients\u2019 parents to gather additional details regarding clinical outcomes and adverse reactions to doxycycline. Descriptive statistics were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:\u2002<\/jats:title>\n            <jats:p>A total of 32 patients were identified through the retrospective case series and 18 participated in the follow-up survey. The most common clinical diagnosis (22\/32; 69%) was single erythema migrans. Seven (22%) had neurological Lyme disease. Three patients (9%) stopped doxycycline treatment prematurely due to adverse effects. During telephone follow-up, 2 children were reported to have dental staining. No patients were identified with treatment failure during the retrospective case series. On telephone follow-up, 3 patients had residual symptoms after treatment, though none were convincing of treatment failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:\u2002<\/jats:title>\n            <jats:p>Our study suggests that doxycycline is generally well-tolerated and an effective treatment of Lyme disease in young children. Prospective, observational studies with long-term assessment of dental staining and clinical outcomes are needed. Alternative antibiotics, principally amoxicillin, remain the preferred treatment of non-neurological Lyme disease manifestations in young children, but doxycycline is likely a safe and effective alternative when needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004128","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:39:41Z","timestamp":1697053181000},"page":"e470-e472","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Doxycycline for the Treatment of Lyme Disease in Young Children"],"prefix":"10.1097","volume":"42","author":[{"given":"Katie","family":"Brown","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Corin","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-4376","authenticated-orcid":false,"given":"Andrew S.","family":"Handel","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York"},{"name":"Division of Infectious Diseases, Stony Brook Children\u2019s Hospital, Stony Brook, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease.","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jpids\/piy072","article-title":"Oral management for pediatric Lyme meningitis.","volume":"8","author":"Lopez","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/1060028019863796","article-title":"Doxycycline and tooth discoloration in children: changing of recommendations based on evidence of safety.","volume":"53","author":"Stultz","year":"2019","journal-title":"Ann Pharmacother"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/hpeds.2021-005909","article-title":"Changes in antibiotic treatment for children with Lyme meningitis 2015-2020.","volume":"11","author":"Roelf","year":"2021","journal-title":"Hosp Pediatr"},{"key":"R6-20250614","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease.","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0000000000003372","article-title":"Oral azithromycin versus doxycycline in the treatment of children with uncomplicated scrub typhus: a randomized controlled trial.","volume":"41","author":"Kabir","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diagmicrobio.2018.09.015","article-title":"How safe is doxycycline for young children or for pregnant or breastfeeding women?","volume":"93","author":"Wormser","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12936-017-1797-9","article-title":"The end of a dogma: the safety of doxycycline use in young children for malaria treatment.","volume":"16","author":"Gaillard","year":"2017","journal-title":"Malar J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:09:49Z","timestamp":1749946189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004128","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}